Advertisement

AP Newswire

Stateside World Business Stocks Technology Sports Weather
Entertainment Multimedia Health Science Politics Travel Offbeat
Mar 25, 10:43 AM EDT

FDA approves new drug for anthrax poisoning


Multimedia
When Drugs Stop Working
Lone Protestor Rallies Ohio City Against Drugs
From Drug Addict to Counselor
Documents
CDC Report on Sexual Behavior and Drug Use
Latest News
Science, patients driving rare disease drug research surge

FDA approves new drug for anthrax poisoning

Latest News
FDA approves new drug for anthrax poisoning

Interactives
Timeline: Major Developments Since the 2001 Anthrax Attacks
Competing for Contagions: Communities Vie for Anthrax Lab
Buy AP Photo Reprints
Multimedia
Drug war interactive

WASHINGTON (AP) -- Federal health officials say they have approved an infusible drug to treat patients who have been exposed to anthrax.

The Food and Drug Administration approved Anthrasil for use in combination with older antibiotics to treat inhalation anthrax, which can cause serious injury and death. The condition occurs when the bacterial spores that carry anthrax are inhaled.

Anthrasil is made from the blood plasma of people who have been vaccinated against anthrax. They carry antibodies against the toxic bacteria.

The drug's development was funded by the U.S. government's Biomedical Advanced Research and Development Authority, which stockpiles vaccines, drugs and equipment for use during pandemics and other health emergencies.

The FDA approved the drug based efficacy data from animal studies and human safety studies. It is manufactured by Cangene Corporation of Canada.

© 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed. Learn more about our Privacy Policy and Terms of Use.

Advertisement

 

 

Advertisement
Advertisement